Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding
Authors:
Open Access
- 1 June 2016
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 62 (3) , 243-247
Abstract
SUMMARY Introduction: Hepatic encephalopathy (HE) is a bad prognostic factor in patients with liver cirrhosis and its incidence is associated with several triggering factors being the most prevalent gastrointestinal bleeding. Lactulose, despite its questionable efficacy in the literature, is considered a first line treatment in patients with HE. Objective: To evaluate the effectiveness of lactulose in preventing HE in cirrhotic patients with gastrointestinal bleeding. Method: A systematic review of the literature using the Medline scientific database. Only randomized controlled clinical trials evaluating the efficacy of lactulose for HE prophylaxis in cirrhotic patients with gastrointestinal bleeding were included. Results: The incidence of HE in the intervention group was 7%, while the control group was 26% (p=0.01). There was no significant difference in the incidence of mortality in the group treated with lactulose compared to the group that was not treated (p=0.48). Conclusion: Administering lactulose to cirrhotic patients with upper gastrointestinal bleeding reduces the incidence of hepatic encephalopathy.Keywords
This publication has 14 references indexed in Scilit:
- Lactulose Is Highly Potential in Prophylaxis of Hepatic Encephalopathy in Patients with Cirrhosis and Upper Gastrointestinal Bleeding: Results of a Controlled Randomized TrialDigestion, 2013
- Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?Metabolic Brain Disease, 2012
- Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiotaWorld Journal of Gastroenterology, 2012
- Hepatic encephalopathySaudi Journal of Gastroenterology, 2012
- Hepatic encephalopathy: Suspect it early in patients with cirrhosisCleveland Clinic Journal of Medicine, 2011
- Prophylaxis of hepatic encephalopathy in acute variceal bleed: A randomized controlled trial of lactulose versus no lactuloseJournal of Gastroenterology and Hepatology, 2011
- New assessment of hepatic encephalopathyJournal of Hepatology, 2011
- Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trialsBMJ, 2004
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trialsThe Lancet, 2001
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996